• Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Recommendation of "Moderate Buy" from Analysts

    Источник: Buzz FX / 13 янв 2025 02:31:15   America/New_York


    Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Regeneron Pharmaceuticals, Inc.
    Read more...
Опубликовать